Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone for vaginal birth after caesarean
ACTRN12624000103561Phase 3Recruiting
- Sponsor
- The University of Auckland
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in labor onset and vaginal birth after cesarean (VBAC) comparing Mifepristone with Placebo (2 arms). Primary endpoint: Spontaneous labour onset. Started Jul 2024; status: recruiting.
02
Drugs
mifepristone
03
Conditions
labor onsetvaginal birth after cesarean (VBAC)
Beyond the preview
Go deeper on ACTRN12624000103561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000103561.